Non-cutaneous melanoma
MONDO:0006320Melanoma is a malignant tumor of melanocytes, cells that are derived from the neural crest. Although most melanomas arise in the skin, they also may arise from mucosal surfaces or at other sites to which neural crest cells migrate. (PDQ)
Also known as: extracutaneous melanoma, non-cutaneous melanoma
1487 clinical trials for this condition and its sub-types, 6 tagged with Non-cutaneous melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Non-cutaneous melanoma
-
Mucosal melanoma 47 trials
2 sub-types
- Cervix melanoma 1 trial
- Vaginal melanoma 1 trial
-
Vulvar melanoma 3 trials
-
Primary melanoma of the central nervous system 2 trials · 3 incl. sub-types
3 sub-types
- Leptomeningeal melanoma 1 trial Sub-types →
- Meningeal melanomatosis 0 trials
- Spinal cord melanoma 0 trials
-
Digestive system melanoma 0 trials · 2 incl. sub-types
3 sub-types
- Rectum malignant melanoma 1 trial · 2 incl. sub-types Sub-types →
- Esophageal melanoma 1 trial
- Gallbladder melanoma 1 trial
Most studied deeper sub-types
-
New combo therapy aims to extend life in advanced melanoma
Disease control Recruiting nowThis study tests a new drug, tebentafusp, alone or with pembrolizumab, in people with a specific genetic type (HLA-A*02:01) of advanced melanoma that has been treated before. The main goal is to see if these treatments help people live longer compared to other available options. …
Phase 3 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for hard-to-treat cancers? early trial launches for GV20-0251
Disease control Recruiting nowThis early-phase study tests a new drug called GV20-0251 in people with advanced solid tumors (like liver, lung, or skin cancer) that have stopped responding to standard therapies. The main goal is to check the drug's safety in a small group of 10 patients. It is not a cure, but …
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC